GnRH Analogues in the Treatment of Endometriosis
article
OA: closed
CC0
⤵ 20 in-corpus citations
AI-generated summary
This paper reviews the current applications and emerging uses of gonadotropin-releasing hormone (GnRH) analogues in managing endometriosis symptoms and disease progression.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Modifications of the native gonadotropin-releasing hormone (GnRH) decapeptide have led to longer-acting compounds with increased binding ability. Pharmacologic doses of agonists result in suppression of ovarian estradiol production to levels similar to oophorectomized patients. The resultant hypoestrogenism is associated with regression in endometrial implant size. Both subjective and objective clinical improvement have been reported. Recent studies document that a reversible state of hypogonadism is effective treatment for endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (77)
- Administration of Nasal Nafarelin as Compared with Oral Danazol for Endometriosis via openalex
- A preliminary report on the comparative use of buserelin (Hoe 766) and danazol in the treatment of endometriosis: the University of Southern California experience. via openalex
- Clinical Management of Endometriosis with Luteinizing Hormone - Releasing Hormone Analogues via openalex
- Clinical study on finding optimal dose of a potent LHRH agonist (buserelin) for the treatment of endometriosis--multicenter trial in Japan. via openalex
- Danazol: An antigonadotropic agent in the treatment of pelvic endometriosis via openalex
- Development of an animal model for quantitatively evaluating effects of drugs on endometriosis via openalex
- Efficacy and safety of LHRH agcnist treatment in 10 patients with endometriosis via openalex
- Efficacy of different modalities of LHRH agonist (buserelin) administration on the inhibition of the pituitary-ovarian axis for the treatment of endometriosis. via openalex
- Endometriosis: Role of Ovarian Steroids in Initiation, Maintenance, and Suppression via openalex
- Gonadotropin-Releasing Hormone Agonist Suppresses Ovulation, Menses, and Endometriosis in Monkeys: An Individualized, Intermittent Regimen* via openalex
- Hormonal effects of danazol and medical oophorectomy in endometriosis. via openalex
- Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis. via openalex
- LHRH and analogs: contraceptive and therapeutic considerations. via openalex
- Luteinising hormone releasing hormone agonist in women with endometriosis. via openalex
- Management of endometriosis. via openalex
- “MEDICAL OOPHORECTOMY” USING A LONG-ACTING GNRH AGONIST-A POSSIBLE NEW APPROACH TO THE TREATMENT OF ENDOMETRIOSIS. via openalex
- Medical Reversible Castration with D-Trp-6-LH-RH Microcapsules for the Treatment of Endometriosis via openalex
- Pelvic Endometriosis via openalex
- Potential new treatment of endometriosis: reversible inhibition of pituitary-ovarian function by chronic intranasal administration of a luteinizing hormone-releasing hormone (LH-RH) agonist via openalex
- Prevention of follicular maturation in endometriosis by subcutaneous infusion of luteinizing hormone-releasing hormone agonist started in the luteal phase via openalex
- Suppression of Follicular Maturation by Infusion of a Luteinizing Hormone-Releasing Hormone Agonist Starting during the Late Luteal Phase in the Stumptailed Macaque Monkey via openalex
- The effect of LHRH agonist therapy in the treatment of endometriosis (Dutch experience). via openalex
- The effect of LHRH agonist therapy in the treatment of endometriosis (English experience). via openalex
- Therapeutic hypogonadism induced by a delayed-release preparation of microcapsules of D-Trp-6-luteinizing hormone-releasing hormone: a preliminary study in eight women with endometriosis. via openalex
- The treatment of endometriosis with Danazol. via openalex
- The use of newer progestins in the treatment of endometriosis via openalex
- THE USE OF STILBESTROL FOR ENDOMETRIOSIS via openalex
- Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist. via openalex
- Treatment of endometriosis with a potent agonist of gonadotropin-releasing hormone (nafarelin) via openalex
- W2076512585 via openalex
- W2077563872 via openalex
- W2080810410 via openalex
- W2084296217 via openalex
- W2085645222 via openalex
- W2092022865 via openalex
- W2153177934 via openalex
- W2396963332 via openalex
- W2408619637 via openalex
- W2409102979 via openalex
- W2409607049 via openalex
- W2410955081 via openalex
- W2477008945 via openalex
- W2481241320 via openalex
- W4230106050 via openalex
- W4296792766 via openalex
- W6607058909 via openalex
- W6633864801 via openalex
- W6702278384 via openalex
- W6714082336 via openalex
- W1422926146 via openalex
- W1565139074 via openalex
- W1567489287 via openalex
- W1618997004 via openalex
- W1872242574 via openalex
- W1966263569 via openalex
- W1987435783 via openalex
- W1989313073 via openalex
- W1991618721 via openalex
- W1992880276 via openalex
- W1996975556 via openalex
- W2012407113 via openalex
- W2013895507 via openalex
- W2014955036 via openalex
- W2016065996 via openalex
- W2022004931 via openalex
- W2024776674 via openalex
- W2032340700 via openalex
- W2032853276 via openalex
- W2034496535 via openalex
- W2042415727 via openalex
- W2047032520 via openalex
- W2048041946 via openalex
- W2049947649 via openalex
- W2056852027 via openalex
- W2068758998 via openalex
- W2074185602 via openalex
- W2075860102 via openalex
Cited by (20)
- Raloxifene Administration in Women Treated with Long Term Gonadotropin-releasing Hormone Agonist for Severe Endometriosis: Effects on Bone Mineral Density 2016
- Pregnancy affects morphology of induced endometriotic lesions in a mouse model through alteration of proliferation and angiogenesis 2014
- Development and evaluation of two mouse models for endometriosis focused on the involvement of the immune system in endometriosis establishment 2008
- Endometriose torácica 2008
- Endometriose torácica 2008
- Medical and Surgical Therapies for Pain Associated with Endometriosis 2001
- Long-term use of gonadotropin-releasing hormone analogs and hormone replacement therapy in the management of endometriosis: a randomized trial with a 6-year follow-up 2000
- Comparison between medical treatment by GnRH analogue (goserelin) and conservative surgery by laparoscopic diathermy for the management of endometriosis 1998
- Cyclic and individualized administration of gonadotropin-releasing hormone agonists plus progestogens: An alternative protocol for contraception 1997
- Effectiveness of tibolone on hypoestrogenic symptoms induced by goserelin treatment in patients with endometriosis 1997
- Long-acting triptorelin for the treatment of endometriosis 1996
- The Role of Medical Management in the Treatment of Endometriosis 1995
- Successful conservative treatment of catamenial pneumothorax with GnRH agonist 1995
- Vesical endometriosis 12 years after a cesarean section 1994
- Laparoscopic Partial Cystectomy for Vesical Endometrioma 1993
- Gonadotropin-releasing hormone agonists: Strategies formanaging the hypoestrogenic effects of therapy 1992
- Case 33-1992 1992
- Recurring Catamenial Pneumothorax Treated with a Gn-RH Analogue 1991
- Extrapelvic endometriosis 1991
- Medical treatment of mild endometriosis associated with infertility 1991
Source provenance
- europepmc
- last seen: 2026-08-30T09:23:35.175841+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:09:15.954262+00:00
- unpaywall
- last seen: 2026-08-30T06:25:36.955031+00:00
License: CC0
· commercial use OK